us en false false Default
Skip directly to Accessibility Notice
PPH VanEck Pharmaceutical ETF Please read important disclosure Close important disclosure false

PPH
VanEck Pharmaceutical ETF

PPH
VanEck Pharmaceutical ETF

  • NAV
    $99.65

    as of December 05, 2025
  • YTD RETURNS
    17.46%

    as of December 05, 2025
  • Total Net Assets
    $1.19B

    as of December 05, 2025
  • Total Expense Ratio
    0.36%
  • Inception Date
    12/20/2011

About PPH

VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Buy Now
Let's Connect
Subscribe

Overview

Why PPH

  • Highly Liquid Companies: Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume
  • Industry Leaders: Index methodology favors the largest companies in the industry
  • Global Scope: Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation

Performance

Performance History:

Average Annual Total Returns* (%)

View All ETFs View All Indices
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 10.84 15.85 20.88 16.29 12.21 11.62 6.75 9.99
PPH (Share Price) 10.77 15.82 20.88 16.26 12.25 11.62 6.73 10.07
MVPPHTR (Index) 10.83 15.87 20.50 15.80 11.73 11.23 6.52 9.80
Performance Differential (NAV - Index) 0.01 -0.02 0.38 0.49 0.48 0.39 0.23 0.19
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 1.63 3.39 6.05 -2.88 12.60 9.85 5.68 9.08
PPH (Share Price) 1.67 3.44 6.11 -2.77 12.61 9.82 5.68 9.16
MVPPHTR (Index) 1.65 3.37 5.71 -3.33 12.10 9.46 5.45 8.89
Performance Differential (NAV - Index) -0.02 0.02 0.34 0.45 0.50 0.39 0.23 0.19

*Returns less than one year are not annualized.

The performance data quoted represents past performance. Past performance is not a guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Please call 800.826.2333 or visit vaneck.com for performance current to the most recent month ended.

Prices as of 12/05/2025

NAV/
Market
Price 		Volume
30-Day Avg./
Last Trading Day 		Daily Change
NAV/
Last Price 		YTD Change NAV/
Last Price 		Premium/
Discount 		30-Day
Median
Bid Ask
Spread 		NAV
Chart
PPH $99.65
$99.61 		483,170
163,806 		$-0.22 / -0.22%
$-0.24 / -0.24% 		+17.46%
+17.47% 		$-0.04
-0.04% 		0.03%

Fees

Holdings

Daily Holdings (%) as of 12/04/2025

Download XLS Get holdings
Total Holdings: 26
Ticker
 Holding Name % of Net
Assets
Identifier (FIGI)
Shares
 Asset Class Market Value
(US$) 		Notional Value
LLY US
 Eli Lilly & Co 23.88
BBG000BNBDC2
281,834
 Stock 285,917,775 --
NVS US
 Novartis Ag 9.06
BBG000LYF3S8
819,032
 Stock 108,464,408 --
MRK US
 Merck & Co Inc 8.06
BBG000BPD168
956,736
 Stock 96,525,095 --
NVO US
 Novo Nordisk A/S 6.03
BBG000BQBKR3
1,504,479
 Stock 72,199,947 --
GSK US
 Gsk Plc 4.79
BBG000BLB481
1,181,508
 Stock 57,385,844 --
PFE US
 Pfizer Inc 4.65
BBG000BR2B91
2,164,007
 Stock 55,614,980 --
MCK US
 Mckesson Corp 4.61
BBG000DYGNW7
67,787
 Stock 55,190,820 --
JNJ US
 Johnson & Johnson 4.60
BBG000BMHYD1
272,204
 Stock 55,115,866 --
AZN US
 Astrazeneca Plc 4.45
BBG000BZ0DK8
592,160
 Stock 53,312,165 --
BMY US
 Bristol-Myers Squibb Co 4.40
BBG000DQLV23
1,014,946
 Stock 52,726,445 --
ABBV US
 Abbvie Inc 4.32
BBG0025Y4RY4
226,115
 Stock 51,714,762 --
SNY US
 Sanofi Sa/France 4.14
BBG000BBD5N1
1,014,716
 Stock 49,619,612 --
COR US
 Cencora Inc 3.59
BBG000MDCQC2
127,402
 Stock 43,014,737 --
ZTS US
 Zoetis Inc 3.22
BBG0039320N9
320,221
 Stock 38,557,811 --
HLN US
 Haleon Plc 2.79
BBG018GZNCH6
3,498,948
 Stock 33,344,974 --
TAK US
 Takeda Pharmaceutical Co Ltd 2.29
BBG000LF8708
1,922,095
 Stock 27,447,517 --
TEVA US
 Teva Pharmaceutical Industries Ltd 2.25
BBG000C0CD58
947,405
 Stock 26,915,776 --
JAZZ US
 Jazz Pharmaceuticals Plc 0.61
BBG000G9CGL0
43,655
 Stock 7,286,456 --
VTRS US
 Viatris Inc 0.58
BBG00Y4RQNH4
642,096
 Stock 6,908,953 --
ELAN US
 Elanco Animal Health Inc 0.43
BBG00LJYS1P8
233,901
 Stock 5,143,483 --
CORT US
 Corcept Therapeutics Inc 0.38
BBG000BKJG33
54,266
 Stock 4,594,160 --
AXSM US
 Axsome Therapeutics Inc 0.35
BBG00B6G7GL7
28,358
 Stock 4,198,118 --
BHC US
 Bausch Health Cos Inc 0.14
BBG000DLFM21
220,321
 Stock 1,625,969 --
OGN US
 Organon & Co 0.10
BBG00ZQRGW24
175,529
 Stock 1,253,277 --
PRGO US
 Perrigo Co Plc 0.08
BBG000CNFQW6
72,126
 Stock 972,980 --
-USD CASH-
 0.00
--
5,085
 Cash Bal 5,085 --
--
Other/Cash 0.19
--
0
 Cash 2,219,429 --
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Portfolio

Sector Weightings (%) as at 11/30/2025

  • Sector

    % of Net Assets

  • Health Care

    99.84

  • Other/Cash

    0.16

Country Weightings (%) as at 11/30/2025

  • Country

    % of Net Assets

  • United States

    64.82

  • United Kingdom

    11.85

  • Switzerland

    8.69

  • Denmark

    6.04

  • France

    4.12

  • Japan

    2.25

  • Israel

    2.07

  • Other/Cash

    0.16

Distributions

Yields  as of  12/05/2025

Distribution Frequency

Quarterly

30-Day SEC Yield

1.87%

Distribution Yield

1.58%

12 Month Yield

1.94%

Yield information reflects temporary waivers of expenses and/or fees. Yields would have been reduced had these fees/expenses been included. In the absence of temporary expense waivers or reimbursements, the 30-Day SEC Yield for VanEck Pharmaceutical ETF would have been 1.87% on 12/05/25. Distributions may vary from time to time.

Team

Literature

PPH